689 related articles for article (PubMed ID: 28847562)
1. Cannabis use during pregnancy: Pharmacokinetics and effects on child development.
Grant KS; Petroff R; Isoherranen N; Stella N; Burbacher TM
Pharmacol Ther; 2018 Feb; 182():133-151. PubMed ID: 28847562
[TBL] [Abstract][Full Text] [Related]
2. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
3. Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects.
Breit KR; Rodriguez CG; Lei A; Thomas JD
Neurotoxicol Teratol; 2020; 82():106930. PubMed ID: 33086086
[TBL] [Abstract][Full Text] [Related]
4. Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development.
Breit KR; Rodriguez CG; Lei A; Hussain S; Thomas JD
Alcohol Clin Exp Res; 2022 Aug; 46(8):1408-1422. PubMed ID: 35722858
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.
Richardson KA; Hester AK; McLemore GL
Neurotoxicol Teratol; 2016; 58():5-14. PubMed ID: 27567698
[TBL] [Abstract][Full Text] [Related]
6. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
7. Maternal-fetal transmission of delta-9-tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats.
Baglot SL; VanRyzin JW; Marquardt AE; Aukema RJ; Petrie GN; Hume C; Reinl EL; Bieber JB; McLaughlin RJ; McCarthy MM; Hill MN
J Neurosci Res; 2022 Mar; 100(3):713-730. PubMed ID: 34882838
[TBL] [Abstract][Full Text] [Related]
8. Gestational exposure to Δ
Martínez-Peña AA; Lee K; Petrik JJ; Hardy DB; Holloway AC
J Dev Orig Health Dis; 2021 Dec; 12(6):865-869. PubMed ID: 33407988
[TBL] [Abstract][Full Text] [Related]
9. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
Goullé JP; Guerbet M
Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
[TBL] [Abstract][Full Text] [Related]
10. Maternal Delta-9-Tetrahydrocannabinol Exposure Induces Abnormalities of the Developing Heart in Mice.
Robinson GI; Ye F; Lu X; Laviolette SR; Feng Q
Cannabis Cannabinoid Res; 2024 Feb; 9(1):121-133. PubMed ID: 36255470
[No Abstract] [Full Text] [Related]
11. Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes.
Shorey-Kendrick LE; Roberts VHJ; D'Mello RJ; Sullivan EL; Murphy SK; Mccarty OJT; Schust DJ; Hedges JC; Mitchell AJ; Terrobias JJD; Easley CA; Spindel ER; Lo JO
Clin Epigenetics; 2023 Jul; 15(1):104. PubMed ID: 37415206
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review.
Roncero C; Valriberas-Herrero I; Mezzatesta-Gava M; Villegas JL; Aguilar L; Grau-López L
Reprod Health; 2020 Feb; 17(1):25. PubMed ID: 32066469
[TBL] [Abstract][Full Text] [Related]
13. Prenatal cannabis exposure and infant outcomes: overview of studies.
Huizink AC
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():45-52. PubMed ID: 24075896
[TBL] [Abstract][Full Text] [Related]
14. The impact of pregnancy and associated hormones on the pharmacokinetics of Δ
Authement AK; Isoherranen N
Expert Opin Drug Metab Toxicol; 2024; 20(1-2):73-93. PubMed ID: 38258511
[TBL] [Abstract][Full Text] [Related]
15. Detection of in utero cannabis exposure by umbilical cord analysis.
Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
[TBL] [Abstract][Full Text] [Related]
16. Cannabis and synaptic reprogramming of the developing brain.
Bara A; Ferland JN; Rompala G; Szutorisz H; Hurd YL
Nat Rev Neurosci; 2021 Jul; 22(7):423-438. PubMed ID: 34021274
[TBL] [Abstract][Full Text] [Related]
17. Cannabis use during pregnancy and postpartum.
Badowski S; Smith G
Can Fam Physician; 2020 Feb; 66(2):98-103. PubMed ID: 32060189
[TBL] [Abstract][Full Text] [Related]
18. Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes.
Smid MC; Metz TD; McMillin GA; Mele L; Casey BM; Reddy UM; Wapner RJ; Thorp JM; Saade GR; Tita ATN; Miller ES; Rouse DJ; Sibai B; Costantine MM; Mercer BM; Caritis SN;
Obstet Gynecol; 2022 Jan; 139(1):21-30. PubMed ID: 34856574
[TBL] [Abstract][Full Text] [Related]
19. The clinical toxicology of cannabis.
Schep LJ; Slaughter RJ; Glue P; Gee P
N Z Med J; 2020 Oct; 133(1523):96-103. PubMed ID: 33032307
[TBL] [Abstract][Full Text] [Related]
20. Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring.
Bolhuis K; Kushner SA; Yalniz S; Hillegers MHJ; Jaddoe VWV; Tiemeier H; El Marroun H
Schizophr Res; 2018 Dec; 202():322-327. PubMed ID: 29983267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]